• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Canadian cardiologist publishes world first mitral regurgitation…

Bioengineer.org by Bioengineer.org
January 29, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Courtesy of St. Michael's Hospital

TORONTO, May 19, 2017– A Canadian cardiologist has published a report in the journal Eurointervention describing how he used a Canadian-invented device for the first time in the world to successfully insert a MitraClip® through a patient's jugular vein rather than the femoral vein.

When Dr. Neil Fam examined his 86-year-old patient with severe mitral regurgitation–a condition in which the blood flows backward into the heart after it contracts–his options for treating her were limited.

Because of her age and overall health, Ortensia Aceti of Sault Ste. Marie, Ont., was not a good candidate for surgery to repair her mitral valve, the flap between the two left chambers of her heart. She had been in and out of hospital with heart failure and medication was no longer controlling her symptoms.

Instead, he decided on a catheter-based treatment to guide a MitraClip device to the heart and clamp the leaky valve. The catheter would usually be inserted through the femoral vein in the leg, but her vein was blocked.

"We were locked out, blocked from accessing her heart," said Dr. Fam, an interventional cardiologist and director of the Cardiac Intensive Care Unit of St. Michael's Hospital in Toronto.

Dr. Fam recalled a conversation he had about a year previously with Baylis Medical Company, Inc., a Canadian supplier of high-tech cardiology equipment, about one of their devices that was designed to achieve access to the heart from alternative approaches.

For the first time in the world, Dr. Fam successfully used the company's SupraCross RF Solution to guide a MitraClip device through the jugular vein – a more direct route to the heart — and successfully repair Mrs. Aceti's leaking mitral valve.

Dr. Fam said this was possible, despite the awkward angle of the jugular vein in relation to the heart, because the tip of the sheath is steerable and the wire is equipped to deliver radiofrequency energy to puncture the septum of the heart. This allows the physician to position the system appropriately from this challenging angle and puncture the septum of the heart in a precise and controlled manner without using excessive force. The septum is the dividing wall between the left and right sides of the heart and it's the last barrier to getting to the mitral valve, which sits between the left ventricle and the left atrium.

Dr. Fam said Mrs. Aceti had no complications and her condition improved, allowing her to be discharged to her home. At a followup appointment, she was doing well with no further heart failure.

Sue Carlucci, one of Mrs. Aceti's three daughters, said that Dr. Fam explained the novel procedure to the family carefully in advance.

"If Dr. Fam hadn't suggested this procedure, we probably would have lost our mom," she said.

"He's our angel," she said, referring to St. Michael's nickname, the Urban Angel.

Dr. Fam said that while this procedure would be appropriate for only selected patients, they are high-risk patients for which there may be no other treatment options.

"Given the success of this procedure, the door is open for future studies of the jugular approach for treating the mitral valve," he said.

Dr. Fam published a report of this procedure in Eurointervention on May 9.

###

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 29 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Center, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

For more information, or to interview Dr. Fam please contact:

Leslie Shepherd
Manager, Media Strategy
Phone: 1-416-864-6094
[email protected]
St. Michael's Hospital
Inspired Care. Inspiring Science.

To speak to someone from Baylis, please contact:

Laura Mills
Marketing Manager
Baylis Medical Company
Tel: 905.602.4875 ext. 292
[email protected]
http://www.baylismedical.com

Media Contact

Leslie Shepherd
[email protected]
416-864-6094
@StMikesHospital

http://www.stmichaelshospital.com/

Share14Tweet8Share2ShareShareShare2

Related Posts

blank

Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

August 23, 2025
blank

Harnessing the Power of the Non-Coding Genome to Advance Precision Medicine

August 23, 2025

Moffitt Study Reveals Lymphoma Speeds Up Aging in Immune Cells and Tissues

August 23, 2025

WTAP Drives DNA Repair via m6A-FOXM1 in Liver Cancer

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

Harnessing the Power of the Non-Coding Genome to Advance Precision Medicine

Moffitt Study Reveals Lymphoma Speeds Up Aging in Immune Cells and Tissues

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.